Shopping Cart

Dog Umbilical Cord-derived Mesenchymal Stem Cells – Female

$829.00

UC-MSCs derived from the umbilical cord tissue of a neonatal (day 0) female dog
1 x 106 cells

Description

Mesenchymal stem cells (MSCs) are multipotent stem cells with a high capacity for self-renewal. They can develop into specialized cells of the body such as chondrocytes, osteoblasts, and adipocytes, and their easy accessibility, exceptional genomic stability, and capacity for tissue repair with few immunological and ethical issues make them a favorable cell type for experimental and clinical use. Umbilical cord-derived mesenchymal stem cells (UC-MSCs) have advantages over traditional sources of MSCs, including ease of collection, faster self-renewal, longer multipotency, and additional immunosuppressive properties, making them potentially beneficial in regenerative medicine and tissue engineering.

UC-MSCs were isolated from the umbilical cord tissue of a neonatal (day 0) female canine. The cells are cultured, passaged for purity, cryopreserved, and delivered frozen. Each vial contains 1 x 106 cells in 1 mL volume. Cells are characterized by flow cytometry for CD90, CD105, CD44, CD45, and CD34. UC-MSCs are negative for mycoplasma, yeast, fungi, and bacteria. Cells are assured to further culture using the protocol provided by JangoCell.

Additional information

Species/Breed

Tissue

Age

,

Gender

Specifications

Catalog Number UC-MSC-DBF-05
Lot Number Included with shipment
Country of Manufacture USA
Quantity 1 x 106 cells/vial
Storage Immediately transfer cells from dry ice to liquid nitrogen upon arrival.
Shipping Info Dry ice; Overnight shipping
Product Use This product is for research use only. It is not approved for use in humans, animals, or for diagnostic procedures.
References Corrao S, La Rocca G, Lo lacono M, Corsello T, Farina F and Anzalone R. Umbilical cord revisited: from Wharton’s jelly myofibroblasts to mesenchymal stem cells. Histology and Histopathology. 2013; 28(10):1235-1244. doi: 10.14670/HH-28.1235. Epub 2013 Apr 18.

Kang BJ, Ryu HH, Park SS, Koyama Y, Kikuchi M, Woo HM, Kim WH and Kweon OK. Comparing the osteogenic potential of canine mesenchymal stem cells derived from adipose tissues, bone marrow, umbilical cord blood, and Wharton’s jelly for treating bone defects. Journal of Veterinary Science. 2012; 13(3):299-310. doi: 10.4142/jvs.2012.13.3.299. Epub 2012 Sep 20.

Nagamura-Inoue T and He H. Umbilical cord-derived mesenchymal stem cells: Their advantages and potential clinical utility. World Journal of Stem Cells. 2014; 6(2):195-202. doi: 10.4252/wjsc.v6.i2.195. Epub 2014 Apr 26.

Technical Resources

Coming Soon

Publications

Does your published paper include JangoCell products?

If you publish a paper that includes any of our products, tell us and we will reward you with ONE Free JangoCell product.

That’s right – get 100% off a single JangoCell branded item in our store. Simply contact us and we’ll supply you with a coupon code.